Sonnet BioTherapeutics Holdings, Inc. (SONN)

Dec 2, 2025 - SONN was delisted (reason: merged into PURR)

1.260

-1.840 (-59.35%)

Inactive · Last trade price on Dec 2, 2025

SONN Cash Flow Statement

Financials in millions USD. Fiscal year is October - September.

Millions USD. Fiscal year is Oct - Sep.

Operating Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Net Income	-	-	-	-	-	-16.42
Depreciation & Amortization	0.08	0.08	0.09	0.1	0.06	3.35
Stock-Based Compensation	0.22	0.25	0.88	1.38	0.37	0.15
Other Adjustments	-	0.28	0.97	-0.12	6.83	9.69
Change in Receivables	-	-	-	-	-	0.18
Changes in Inventories	-	-	-	-	-	-0.07
Changes in Accounts Payable	-1.21	-2.63	0.97	1.72	0.17	-
Changes in Accrued Expenses	-2.07	0.23	0.64	0.25	1.11	2.13
Changes in Unearned Revenue	-	-0.15	-0.35	0.02	0.5	-0.22
Changes in Other Operating Activities	0.63	-0.57	-1.26	-0.9	-0.39	-1.83
Operating Cash Flow	-10	-21.34	-27.77	-22.55	-15.61	-4.05
Operating Cash Flow Growth	-	-	-	-	-	-

Investing Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Capital Expenditures	-	-	-	-0	-0.08	-0.47
Sale of Property, Plant & Equipment	-	-	-	-	-	0.53
Purchases of Intangible Assets	-	-0.44	-0.81	-	-	-
Other Investing Activities	-	-	-	-	-	0.63
Investing Cash Flow	-	-0.44	-0.81	-0	-0.08	0.68

Financing Activities

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Long-Term Debt Issued	-	-	-	-	0.24	-
Long-Term Debt Repaid	-	-0	-	-0.02	-0.11	-
Net Long-Term Debt Issued (Repaid)	-	-0	-	-0.02	0.13	-
Issuance of Common Stock	5.8	21.01	1.84	42.85	28.86	2.85
Net Common Stock Issued (Repurchased)	5.8	21.01	1.84	42.85	28.86	2.85
Issuance of Preferred Stock	-	-	2.17	-	-	-
Net Preferred Stock Issued (Repurchased)	-	-	2.17	-	-	-
Other Financing Activities	-	-	-	-	-5.98	0.5
Financing Cash Flow	6.71	21.01	4.01	42.83	23.01	3.34

Net Cash Flow

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Foreign Exchange Rate Adjustments	-	-	-	-	-	0
Net Cash Flow	-3.47	-0.78	-24.57	20.27	7.31	-0.02
Beginning Cash & Cash Equivalents	7.02	3.05	27.62	7.35	0.04	0.52
Ending Cash & Cash Equivalents	3.55	2.27	3.05	27.62	7.35	0.5

Free Cash Flow

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2020
Period Ending	Jun '24 Jun 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021	Sep '20 Sep 30, 2020	Dec '19 Dec 31, 2019
Free Cash Flow	-10	-21.34	-27.77	-22.56	-15.69	-4.52
Free Cash Flow Growth	-	-	-	-	-	-
FCF Margin	-17889.20%	-14439.19%	-7936.59%	-4663.91%	-	-14.99%
Free Cash Flow Per Share	-20.67	-164.47	-1125.22	-2264.11	-4104.09	-41487.20
Levered Free Cash Flow	-14.87	-21.87	-29.62	-23.83	-64.1	-14.83
Unlevered Free Cash Flow	-14.84	-21.83	-29.57	-23.91	-22.86	-13.24

SEC Filings: 10-K · 10-Q